Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-641


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 340, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
MGAT4A hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr2:98624660-98624686 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ACTN1 hsa-miR-641 low: 0 high: 1 1 1 1 0.508
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr14:68874556-68874583 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CA12 hsa-miR-641 low: 0 high: 1 1 1 1 0.456
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr15:63324638-63324658 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FNDC3B hsa-miR-641 low: 0 high: 1 1 1 1 0.941
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr3:172398245-172398273 HITS-CLIP POSITIVE DIRECT TarBase 7.0
GTF3C1 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr16:27484286-27484292 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NRD1 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr1:51837542-51837562 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SAR1A hsa-miR-641 low: 0 high: 1 1 1 1 0.596
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr10:70157818-70157840 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SESN1 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr6:108986762-108986779 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SRCAP hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr16:30724602-30724625 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TNPO1 hsa-miR-641 low: 0 high: 1 1 1 1 0.591
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr5:72910395-72910423 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PDS5B hsa-miR-641 low: 0 high: 1 1 1 1 0.758
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr13:32764523-32764541 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZNF264 hsa-miR-641 low: 0 high: 1 1 1 1 0.909
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr19:57212043-57212069 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CHMP2B hsa-miR-641 low: 0 high: 1 1 1 1 0.572
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr3:87254216-87254240 HITS-CLIP POSITIVE DIRECT TarBase 7.0
LPCAT2 hsa-miR-641 low: 0 high: 1 1 1 1 0.684
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr16:55574656-55574683 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CNOT3 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr19:54142274-54142301 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SUPT16H hsa-miR-641 low: 0 high: 1 1 1 1 0.452
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr14:21369726-21369754 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CDC23 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr5:138188992-138189017 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CBX5 hsa-miR-641 low: 0 high: 1 1 1 1 0.825
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:54234970-54234997 PAR-CLIP POSITIVE DIRECT TarBase 7.0
SUCO hsa-miR-641 low: 0 high: 1 1 1 1 0.935
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr1:172611810-172611828 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MAP3K1 hsa-miR-641 low: 0 high: 1 1 1 1 0.821
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr5:56896098-56896126 HITS-CLIP POSITIVE DIRECT TarBase 7.0